1176451

Hikma Pharmaceuticals USA Inc. — FEI 2220525

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 7, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cherry Hill, NJ (United States)